Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jeffrey Bluestone

At a glance: Jeffrey Bluestone is Director at Gilead Sciences (GILD). Their latest SEC Form 4, filed Aug 21, 2026, reported a sale of $167K. On file: 0 purchase lines ($0) and 7 sale lines ($2.0M).

Disclosed holdings: about $1.7M of GILD stock: 10,066 shares reported on their latest Form 4 (filed Aug 21, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Gilead Sciences, Inc. (GILD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M

Jeffrey Bluestone's InsiderPrint

7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Jeffrey Bluestone: 7 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 6 sales

Reading this print: Almost only sells, trading about 7 times a year, typically $242K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (7)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Michael Patsalos-FoxDirector · CTSH · 99% match
  2. Victor K. LeeDirector · MPWR · 99% match
  3. Mani SundaramEvp And Gm Security · AKAM · 99% match
  4. Joshua ScuttPresident · PCTY · 99% match
  5. Peter J. BulgarelliCEO · VTR · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 21SEC GILDGilead Sciences, Inc. Sell Plan 1,16510,066 held (−10%) $143.75 $167K +16.3%
Aug 21SEC GILDGilead Sciences, Inc. Sell Plan 1,81610,066 held (−15%) $144.92 $263K +15.3%
Aug 21SEC GILDGilead Sciences, Inc. Sell Plan 1,65810,066 held (−14%) $145.73 $242K +14.7%
Aug 21SEC GILDGilead Sciences, Inc. Sell Plan 2610,066 held (−0%) $146.36 $4K +14.2%
Aug 21SEC GILDGilead Sciences, Inc. Sell Plan 33510,066 held (−3%) $146.26 $49K +14.3%
Jan 21SEC GILDGilead Sciences, Inc. Sell Plan 5,0008,920 held (−36%) $123.50 $618K +35.3%
Dec 1SEC GILDGilead Sciences, Inc. Sell 5,0008,920 held (−36%) $125.08 $625K +33.6%
  • Sell

    Director Jeffrey Bluestone sold $167K of GILD at $143.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jeffrey Bluestone sold $263K of GILD at $144.92 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jeffrey Bluestone sold $242K of GILD at $145.73 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jeffrey Bluestone sold $4K of GILD at $146.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jeffrey Bluestone sold $49K of GILD at $146.26 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Jeffrey Bluestone sold $618K of GILD at $123.50 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.

Follow Jeffrey Bluestone

Get one email when Jeffrey Bluestone files a new purchase or sale. Free.

At most one email a day about Jeffrey Bluestone, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.